WOODCLIFF LAKE, N.J. & HENDERSON, Nev.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) (“Eagle” or the “Company”) and Spectrum Pharmaceuticals (NASDAQ:SPPI) (“Spectrum”) today announced that they have entered into a co-promotion agreement (“the agreement”) under which the Spectrum 32-person Corporate Accounts Sales Team will dedicate 80 percent of its time to selling and marketing up to six Eagle products over a period of at least 18 months. Spectrum will continue to maintain a separate sales force to market existing and potential hematology products.
Help employers find you! Check out all the jobs and post your resume.
